Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Lattice Biologics Ltd (TSE:LBL.H)
TSXV:LBL.H
Lattice Biologics (LBL.H) Stock Price & Analysis
3 Followers
LBL.H Stock Chart & Stats
Day’s RangeC$0 - C$0
52-Week RangeC$0.04 - C$0.04
Previous CloseC$0.04
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueC$3.68M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
BetaN/A
Next Earnings
Jun 01, 2023EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding128,218,300
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation1.23
R-Squared0.54
Alpha0.38
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)14.55
Price to Cash Flow (P/CF)N/A
P/FCF Ratio602.80
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.36
Enterprise Value/Gross Profit3.61
Enterprise Value/Ebitda-30.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Options Prices
Currently, No data available
---
Ownership Overview
76.92%
Insiders
0.00% Mutual Funds
0.02% Other Institutional Investors
23.06% Public Companies and
Individual Investors
LBL.H FAQ
What was Lattice Biologics Ltd’s price range in the past 12 months?
Lattice Biologics Ltd lowest stock price was C$0.04 and its highest was C$0.04 in the past 12 months.
What is Lattice Biologics Ltd’s market cap?
Currently, no data Available
When is Lattice Biologics Ltd’s upcoming earnings report date?
Lattice Biologics Ltd’s upcoming earnings report date is Jun 01, 2023 which is 418 days ago.
How were Lattice Biologics Ltd’s earnings last quarter?
Currently, no data Available
Is Lattice Biologics Ltd overvalued?
According to Wall Street analysts Lattice Biologics Ltd’s price is currently same.
Does Lattice Biologics Ltd pay dividends?
Lattice Biologics Ltd does not currently pay dividends.
What is Lattice Biologics Ltd’s EPS estimate?
Lattice Biologics Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Lattice Biologics Ltd have?
Lattice Biologics Ltd has 96,944,756 shares outstanding.
What happened to Lattice Biologics Ltd’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Lattice Biologics Ltd?
Currently, no hedge funds are holding shares in TSE:LBL.H
---
Lattice Biologics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
Lattice Biologics Ltd
Lattice Biologics Ltd is a biologic product manufacturing company. It manufactures and markets the biologic products to domestic and international markets. The products of the company include ADM dermis, DBM Putty, Bone scaffold and Others, of which key revenue is derived from Bone scaffold. The biologic products are used in various applications such as enhancing fusion in spine surgery, enhancing breast reconstruction post mastectomy for breast cancer patients, sports medicine applications, promotion of bone in foot and ankle surgery, promotion of skull healing following neurosurgery, and subchondral bone defect repair in knee and other joint surgeries. The company generates its revenue from operations principally carried in the United States of America.
---
Technical Analysis
Tetra Bio-Pharma
―
Reliq Health Technologies
―
Scopus BioPharma
―
Bone Biologics
―
---